<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03590405</url>
  </required_header>
  <id_info>
    <org_study_id>Sahlgrenska-BMC-UTx</org_study_id>
    <nct_id>NCT03590405</nct_id>
  </id_info>
  <brief_title>Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC</brief_title>
  <acronym>GOT-BMC-UTx</acronym>
  <official_title>Uterus Transplantation LD - Feasibility Study - Sahlgrenska - Bellevue Medical Centre</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Saint Joseph University, at Bellevue Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medical know-how concerning uterus transplantation will be transferred to new site by
      structured process involving theory, animal workshops and a clinical feasibility study on
      human subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medical know-how concerning uterus transplantation will be transferred to new site by
      structured process involving theory, animal workshops and surgery.

      Theory and common animal workshops have been ongoing for 3 years. The team from Bellevue
      Medical Centre is affiliated to St Joseph, University, Beirut
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth</measure>
    <time_frame>3 years</time_frame>
    <description>live birth</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Mrk Anomaly</condition>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>uterus transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>uterus transplantation from living donor with the donor being close relative</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>uterus transplantation surgery and IVF</intervention_name>
    <description>IVF before surgery living donor uterus transplantation ET</description>
    <arm_group_label>uterus transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria recipient

          -  age &lt; 38 years

          -  psychologicaly stable

          -  BMI &lt; 35

          -  no systemic disease

          -  no standing medication

          -  in a stable relationship or married

          -  normal ovarian reserve

          -  absolute uterine factor infertility

          -  normal kidney function

        Inclusion criteria donor

          -  close relative to recipient

          -  age &lt; 60 years

          -  normal pregnancies

          -  maximum two cesarean sections

          -  BMI &lt; 35

          -  no major systemic disease

          -  no previous major surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mats Brännström, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mats Brännström, MD, PhD</last_name>
    <phone>+46736254455</phone>
    <email>mats.brannstrom@obgyn.gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna-Karin Tholin</last_name>
    <email>anna-karin.tholin@vgregion.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mats Brännström, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mats Brännström</name>
      <address>
        <city>Göteborg</city>
        <zip>SE-41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mats Brännström, MD, PhD</last_name>
      <phone>+46736254455</phone>
      <email>mats.brannstrom@obgyn.gu.se</email>
    </contact>
    <investigator>
      <last_name>Mats Brännström, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 17, 2018</study_first_submitted>
  <study_first_submitted_qc>July 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2018</study_first_posted>
  <last_update_submitted>July 20, 2018</last_update_submitted>
  <last_update_submitted_qc>July 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Mats Brännström</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>uterus</keyword>
  <keyword>infertility</keyword>
  <keyword>transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

